Showing results (141-150 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trialGiuseppe Luigi Banna, Alfredo Addeo, Panagiota Zygoura, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2022
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directionsMariona Riudavets, Priscilla Cascetta, David Planchard
Lung Cancer (Amsterdam, Netherlands)|June 24, 2022
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomasPhilipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2022
Assessment of treatment strategies for stage I non-small cell lung cancer in patients with comorbiditiesKeith Sigel, Chung Yin Kong, Amanda Leiter, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2022
Air pollution and lung cancer survival in PennsylvaniaThomas P McKeon, Anil Vachani, Trevor M Penning, et al.
Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2020
ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer careBrendan McCann, Riccardo Muhr, Noelle O'Rourke, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2021
Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectivesStanislav Lazarev, Kenneth Rosenzweig, Robert Samstein, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 2021
Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT)Katrina M Ingley, Debbie Hughes, Michael Hubank, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2021
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysisViola W Zhu, Joseph J Zhao, Yanfei Gao, et al.
Pageof 700